Systemic adoptive T-cell immunotherapy in recurrent and metastatic carcinoma of the head and neck: a phase 1 study.
To WC, Wood BG, Krauss JC, Strome M, Esclamado RM, Lavertu P, Dasko D, Kim JA, Plautz GE, Leff BE, Smith V, Sandstrom-Wakeling K, Shu S.
To WC, et al.
Arch Otolaryngol Head Neck Surg. 2000 Oct;126(10):1225-31. doi: 10.1001/archotol.126.10.1225.
Arch Otolaryngol Head Neck Surg. 2000.
PMID: 11031409
Clinical Trial.